FDA Approves KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in ... - MarketWatch (press release)

TopNews United Kingdom (blog)

FDA Approves KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in ... MarketWatch (press release) KRYSTEXXA has not been formally studied in patients with congestive heart failure, but some patients in the clinical trials experienced exacerbation. ... FDA Approves Pegloticase for Refractory GoutMedscape Krystexxa Approved for GoutBusinessWeek FDA Approves New Gout DrugMedPage Today PR Newswire (press release) -Pharma Times -Technorati all 199 news articles »

Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and ... - PR Newswire (press release)

Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and ... PR Newswire (press release) Patients with concomitant cardiac conditions should be carefully monitored for clinical signs and symptoms of congestive heart failure. ... and more »

Health Buzz: FDA OK's Gout Drug Krystexxa - U.S. News & World Report

Health Buzz: FDA OK's Gout Drug Krystexxa U.S. News & World Report Denollet and his colleagues analyzed 49 previous studies involving more than 6000 people and found that Type D spells trouble—especially for heart patients ... and more »

Old News on Old Cheap Medicines - Blogger News Network (blog)

Old News on Old Cheap Medicines Blogger News Network (blog) And if you have congestive heart failure, they are a good choice, although we often use the stronger loop diuretics (eg Lasix/furosemide) in these cases. ...